Literature DB >> 30706817

Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.

Eleni A Rekka1, Panos N Kourounakis1, Maria Pantelidou2.   

Abstract

BACKGROUND: The biotransformation of xenobiotics is a homeostatic defensive response of the body against bioactive invaders. Xenobiotic metabolizing enzymes, important for the metabolism, elimination and detoxification of exogenous agents, are found in most tissues and organs and are distinguished into phase I and phase II enzymes, as well as phase III transporters. The cytochrome P450 superfamily of enzymes plays a major role in the biotransformation of most xenobiotics as well as in the metabolism of important endogenous substrates such as steroids and fatty acids. The activity and the potential toxicity of numerous drugs are strongly influenced by their biotransformation, mainly accomplished by the cytochrome P450 enzymes, one of the most versatile enzyme systems.
OBJECTIVE: In this review, considering the importance of drug metabolising enzymes in health and disease, some of our previous research results are presented, which, combined with newer findings, may assist in the elucidation of xenobiotic metabolism and in the development of more efficient drugs.
CONCLUSION: Study of drug metabolism is of major importance for the development of drugs and provides insight into the control of human health. This review is an effort towards this direction and may find useful applications in related medical interventions or help in the development of more efficient drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cytochrome P450; Drug design; Drug interactions; Drug metabolising enzymezzm321990induction inhibition; Drug metabolism and pathologic conditions; Xenobiotic metabolism phase I II III.

Mesh:

Substances:

Year:  2019        PMID: 30706817     DOI: 10.2174/1568026619666190129122727

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  2 in total

1.  Dechlorination and demethylation of ochratoxin A enhance blocking activity of PXR activation, suppress PXR expression and reduce cytotoxicity.

Authors:  Yuanjun Shen; Zhanquan Shi; Jun Ting Fan; Bingfang Yan
Journal:  Toxicol Lett       Date:  2020-07-10       Impact factor: 4.372

2.  Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.

Authors:  Entesar M Tebien; Hiba B Khalil; Jeremy Mills; Abozer Y Elderdery
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.